p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Format: Article
Sprog:English
Udgivet: MDPI AG 2022-12-01
Serier:Diagnostics
Fag:
Online adgang:https://www.mdpi.com/2075-4418/12/12/3052